Systemic administration of strontium ranelate to enhance the osseointegration of implants: systematic review of animal studies

被引:0
作者
Cassio Rocha Scardueli
Carolina Bizelli-Silveira
Rosemary Adriana C. Marcantonio
Elcio Marcantonio
Andreas Stavropoulos
Rubens Spin-Neto
机构
[1] Aarhus University,Department of Dentistry and Oral Health
[2] São Paulo State University (Unesp),Department of Periodontology
[3] School of Dentistry,Department of Periodontology, Faculty of Odontology
[4] University of Malmö,undefined
来源
International Journal of Implant Dentistry | / 4卷
关键词
Strontium; Systemic use; Osseointegration; Bone remodeling;
D O I
暂无
中图分类号
学科分类号
摘要
The literature states that Strontium (Sr) is able to simultaneously stimulate bone formation and suppress bone resorption. Recent animal studies suggest that the systemic administration of Sr, in the form of strontium ranelate (SRAN), would enhance the osseointegration of implants. The purpose of the present study was to undertake a systematic review on animal studies evaluating the systemic administration of Sr to enhance the osseointegration of titanium implants and the remodeling of bone grafts. The MEDLINE (PubMed) and Scopus bibliographic databases were searched from 1950 to October 2017 for reports on the use of systemic and non-radioactive Sr to enhance the osseointegration of titanium implants and the remodeling of bone grafts in animals. The search strategy was restricted to English language publications using the combined terms: “strontium” and “implant or graft or biomaterial or bone substitute”. Five studies were included, all related to the systemic administration of Sr in the form SRAN, and its effects on osseointegration of titanium implants. No studies on the use of SRAN-based therapy to enhance the remodeling of bone grafts were found. The studies differed notably with respect to the study population (healthy female rats, healthy male rats, and female rats with induced osteoporosis) and SRAN dose (ranging from 500 to 1000 mg/kg/day). Results were diverse, but a tendency suggesting positive influence of systemic SRAN administration on the osseointegration of titanium implants was observed. No major side-effects due to strontium administration were reported. Systemic Sr administration, in the form of SRAN, seems to enhance peri-implant bone quality and implant osseointegration in animals, however, at a moderate extent. Further studies, evaluating both the effects of this drug on implant osseointegration and the risk/benefit of its use, are needed to provide a rationale of this therapeutic approach.
引用
收藏
相关论文
共 266 条
  • [1] Davies JE(1998)Mechanisms of endosseous integration Int J Prosthodont 11 391-401
  • [2] Davies JE(2003)Understanding peri-implant endosseous healing J Dent Educ 67 932-949
  • [3] Sakka S(2012)Factors associated with early and late failure of dental implants J Investig Clin Dent 3 258-261
  • [4] Baroudi K(2014)Calvarial autogenous bone graft for maxillary ridge and sinus reconstruction for rehabilitation with dental implants J Oral Implantol 40 469-478
  • [5] Nassani MZ(2011)Bone regeneration: current concepts and future directions BMC Med 9 66-104
  • [6] Bastos AS(2017)Systemic drugs that influence titanium implant osseointegration Drug Metab Rev 49 92-285
  • [7] Spin-Neto R(2004)Oestrogen replacement therapy promotes bone healing around dental implants in osteoporotic rats Int J Oral Maxillofac Surg 33 279-282
  • [8] Conte-Neto N(2006)Parathyroid hormone 1-34 enhances titanium implant anchorage in low-density trabecular bone: a correlative micro-computed tomographic and biomechanical analysis Bone 39 276-705
  • [9] Galina K(2010)Additive effects of estrogen replacement therapy and bisphosphonates on osseointegration of hydroxyapatite-coated titanium screws in ovariectomized rats Oral Surg Oral Med Oral Pathol Oral Radiol Endod 109 700-82
  • [10] Boeck-Neto RJ(2008)Effect of ovariectomy and alendronate on implant osseointegration in rat maxillary bone J Oral Implantol. 34 76-2978